Header Logo

Connection

Barish Edil to Adenocarcinoma

Back to Details
This is a "connection" page, showing publications Barish Edil has written about Adenocarcinoma.
Barish Edil
Connection Strength
3.974
Adenocarcinoma
  1. Utility of Viscoelastic Assays Beyond Coagulation: Can Preoperative Thrombelastography Indices Predict Tumor Histology, Nodal Disease, and Resectability in Patients Undergoing Pancreatectomy? J Am Coll Surg. 2018 07; 227(1):55-62.
    View in: PubMed
    Score: 0.499
  2. Comparison of laparoscopic to open pancreaticoduodenectomy in elderly patients with pancreatic adenocarcinoma. Surg Endosc. 2018 05; 32(5):2239-2248.
    View in: PubMed
    Score: 0.485
  3. Laparoscopic pancreaticoduodenectomy: changing the management of ampullary neoplasms. Surg Endosc. 2018 Feb; 32(2):915-922.
    View in: PubMed
    Score: 0.477
  4. Innovative Imaging Techniques Used to Evaluate Borderline-Resectable Pancreatic Adenocarcinoma. J Surg Res. 2023 04; 284:42-53.
    View in: PubMed
    Score: 0.173
  5. Comparing Short-term and Oncologic Outcomes of Minimally Invasive Versus Open Pancreaticoduodenectomy Across Low and High Volume Centers. Ann Surg. 2019 12; 270(6):1147-1155.
    View in: PubMed
    Score: 0.140
  6. ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin a3ß1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells. Gastroenterology. 2020 02; 158(3):679-692.e1.
    View in: PubMed
    Score: 0.140
  7. Perioperative outcomes and survival following neoadjuvant stereotactic body radiation therapy (SBRT) versus intensity-modulated radiation therapy (IMRT) in pancreatic adenocarcinoma. J Surg Oncol. 2018 Apr; 117(5):1073-1083.
    View in: PubMed
    Score: 0.124
  8. Expression of the Novel Costimulatory Molecule B7-H5 in Pancreatic Cancer. Ann Surg Oncol. 2015 Dec; 22 Suppl 3:S1574-9.
    View in: PubMed
    Score: 0.099
  9. Neoadjuvant FOLFIRINOX application in borderline resectable pancreatic adenocarcinoma: a retrospective cohort study. Medicine (Baltimore). 2014 Dec; 93(27):e198.
    View in: PubMed
    Score: 0.099
  10. A safety and feasibility study of an allogeneic colon cancer cell vaccine administered with a granulocyte-macrophage colony stimulating factor-producing bystander cell line in patients with metastatic colorectal cancer. Ann Surg Oncol. 2014 Nov; 21(12):3931-7.
    View in: PubMed
    Score: 0.096
  11. Intercellular adhesion molecule-1 mediates murine colon adenocarcinoma invasion. J Surg Res. 2014 Mar; 187(1):19-23.
    View in: PubMed
    Score: 0.092
  12. Comparison of conventional and 3-dimensional computed tomography against histopathologic examination in determining pancreatic adenocarcinoma tumor size: implications for radiation therapy planning. Radiother Oncol. 2012 Aug; 104(2):167-72.
    View in: PubMed
    Score: 0.084
  13. Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma. J Gastrointest Surg. 2012 Aug; 16(8):1478-86.
    View in: PubMed
    Score: 0.084
  14. Early mortality risk score: identification of poor outcomes following upfront surgery for resectable pancreatic cancer. J Gastrointest Surg. 2012 Apr; 16(4):753-61.
    View in: PubMed
    Score: 0.082
  15. Factors influencing survival in patients undergoing palliative bypass for pancreatic adenocarcinoma. J Surg Oncol. 2012 Jul 01; 106(1):66-71.
    View in: PubMed
    Score: 0.081
  16. Patient readmission and mortality after colorectal surgery for colon cancer: impact of length of stay relative to other clinical factors. J Am Coll Surg. 2012 Apr; 214(4):390-8; discussion 398-9.
    View in: PubMed
    Score: 0.081
  17. Duodenal adenocarcinoma: clinicopathologic analysis and implications for treatment. Ann Surg Oncol. 2012 Jun; 19(6):1928-35.
    View in: PubMed
    Score: 0.081
  18. Management of patients with pancreatic adenocarcinoma: national trends in patient selection, operative management, and use of adjuvant therapy. J Am Coll Surg. 2012 Jan; 214(1):33-45.
    View in: PubMed
    Score: 0.080
  19. Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent. Cancer. 2012 May 15; 118(10):2674-81.
    View in: PubMed
    Score: 0.079
  20. Palliative surgical management of patients with unresectable pancreatic adenocarcinoma: trends and lessons learned from a large, single institution experience. J Gastrointest Surg. 2011 Nov; 15(11):1917-27.
    View in: PubMed
    Score: 0.079
  21. Pulmonary resection for isolated pancreatic adenocarcinoma metastasis: an analysis of outcomes and survival. J Gastrointest Surg. 2011 Sep; 15(9):1611-7.
    View in: PubMed
    Score: 0.078
  22. Re-evaluating the impact of tumor size on survival following pancreaticoduodenectomy for pancreatic adenocarcinoma. J Surg Oncol. 2011 Jun 01; 103(7):656-62.
    View in: PubMed
    Score: 0.076
  23. National trends in the management and survival of surgically managed gallbladder adenocarcinoma over 15 years: a population-based analysis. J Gastrointest Surg. 2010 Oct; 14(10):1578-91.
    View in: PubMed
    Score: 0.074
  24. Adjuvant chemoradiation therapy for adenocarcinoma of the distal pancreas. Ann Surg Oncol. 2010 Dec; 17(12):3112-9.
    View in: PubMed
    Score: 0.073
  25. Impact of obesity on perioperative outcomes and survival following pancreaticoduodenectomy for pancreatic cancer: a large single-institution study. J Gastrointest Surg. 2010 Jul; 14(7):1143-50.
    View in: PubMed
    Score: 0.072
  26. Clinicopathologic analysis of ampullary neoplasms in 450 patients: implications for surgical strategy and long-term prognosis. J Gastrointest Surg. 2010 Feb; 14(2):379-87.
    View in: PubMed
    Score: 0.071
  27. Outcomes of adjuvant chemoradiation after pancreaticoduodenectomy with mesenterico-portal vein resection for adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys. 2010 Jan 01; 76(1):176-80.
    View in: PubMed
    Score: 0.071
  28. Total pancreatectomy for pancreatic adenocarcinoma: evaluation of morbidity and long-term survival. Ann Surg. 2009 Aug; 250(2):282-7.
    View in: PubMed
    Score: 0.068
  29. Peri-operative mortality and long-term survival after total pancreatectomy for pancreatic adenocarcinoma: a population-based perspective. J Surg Oncol. 2009 Feb 01; 99(2):87-92.
    View in: PubMed
    Score: 0.066
  30. Determining pattern of recurrence following pancreaticoduodenectomy and adjuvant 5-flurouracil-based chemoradiation therapy: effect of number of metastatic lymph nodes and lymph node ratio. J Gastrointest Surg. 2009 Apr; 13(4):752-9.
    View in: PubMed
    Score: 0.066
  31. Treatment of locally advanced pancreatic cancer using localized trans-arterial micro perfusion of gemcitabine: combined analysis of RR1 and RR2. Oncologist. 2024 Aug 05; 29(8):690-698.
    View in: PubMed
    Score: 0.048
  32. Correlation of Smad4 status with outcomes in patients receiving erlotinib combined with adjuvant chemoradiation and chemotherapy after resection for pancreatic adenocarcinoma. Int J Radiat Oncol Biol Phys. 2013 Nov 01; 87(3):458-9.
    View in: PubMed
    Score: 0.023
  33. Liver-directed therapy for hepatic metastases in patients undergoing pancreaticoduodenectomy: a dual-center analysis. Ann Surg. 2010 Jul; 252(1):142-8.
    View in: PubMed
    Score: 0.018
  34. Surgical treatment of esophageal high-grade dysplasia. Ann Thorac Surg. 2005 Apr; 79(4):1110-5; discussion 1110-5.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.